CARCINOMA IN SITU

CARCINOMA IN SITU was reported 167 times

These drug classes are most commonly taken by patients reporting CARCINOMA IN SITU:

# Drug Count
0 Corticosteroid [EPC] 24
1 Tumor Necrosis Factor Blocker [EPC] 23
2 Nonsteroidal Anti-inflammatory Drug [EPC] 15
3 Purine Antimetabolite [EPC] 11
4 Folate Analog Metabolic Inhibitor [EPC] 10
5 HMG-CoA Reductase Inhibitor [EPC] 9
6 Alkylating Drug [EPC] 8
7 Progestin [EPC] 8
8 Kinase Inhibitor [EPC] 7
9 Nucleoside Metabolic Inhibitor [EPC] 7
10 Progestin-containing Intrauterine System [EPC] 7
11 Selective T Cell Costimulation Modulator [EPC] 7
12 Aromatase Inhibitor [EPC] 6
13 Microtubule Inhibitor [EPC] 6
14 beta-Adrenergic Blocker [EPC] 6
15 Estrogen [EPC] 5
16 Thiazide Diuretic [EPC] 5
17 Vitamin C [EPC] 5
18 Vitamin D [EPC] 5
19 Angiotensin 2 Receptor Blocker [EPC] 4
20 Benzodiazepine [EPC] 4
21 CD20-directed Cytolytic Antibody [EPC] 4
22 Interferon beta [EPC] 4
23 Interleukin-6 Receptor Antagonist [EPC] 4
24 Loop Diuretic [EPC] 4
25 Proton Pump Inhibitor [EPC] 4
26 Vitamin B12 [EPC] 4
27 alpha-Adrenergic Blocker [EPC] 4
28 GLP-1 Receptor Agonist [EPC] 3
29 Nitrate Vasodilator [EPC] 3
30 mTOR Inhibitor Immunosuppressant [EPC] 3
31 Aminosalicylate [EPC] 2
32 Calcineurin Inhibitor Immunosuppressant [EPC] 2
33 Cytochrome P450 3A Inhibitor [EPC] 2
34 Erythropoiesis-stimulating Agent [EPC] 2
35 Opioid Agonist [EPC] 2
36 Parathyroid Hormone Analog [EPC] 2
37 Platelet Aggregation Inhibitor [EPC] 2
38 Protease Inhibitor [EPC] 2
39 Sphingosine 1-phosphate Receptor Modulator [EPC] 2
40 Sulfonylurea [EPC] 2
41 Acetylcholine Release Inhibitor [EPC] 1
42 Alkaloid [EPC] 1
43 Angiotensin Converting Enzyme Inhibitor [EPC] 1
44 Antirheumatic Agent [EPC] 1
45 Atypical Antipsychotic [EPC] 1
46 Azole Antifungal [EPC] 1
47 CCR5 Co-receptor Antagonist [EPC] 1
48 Cardiac Glycoside [EPC] 1
49 Chloride Channel Activator [EPC] 1
50 Cholinergic Muscarinic Antagonist [EPC] 1
51 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
52 Dietary Cholesterol Absorption Inhibitor [EPC] 1
53 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
54 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
55 GLP-2 Analog [EPC] 1
56 General Anesthetic [EPC] 1
57 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
58 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
59 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
60 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
61 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
62 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
63 Insulin Analog [EPC] 1
64 Interleukin-17A Antagonist [EPC] 1
65 Interleukin-23 Antagonist [EPC] 1
66 Janus Kinase Inhibitor [EPC] 1
67 Leukocyte Growth Factor [EPC] 1
68 Neuromuscular Blocker [EPC] 1
69 Nitroimidazole Antimicrobial [EPC] 1
70 Non-Standardized Plant Allergenic Extract [EPC] 1
71 Osmotic Diuretic [EPC] 1
72 P2Y12 Platelet Inhibitor [EPC] 1
73 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
74 Phosphodiesterase 4 Inhibitor [EPC] 1
75 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
76 Pyrimidine Synthesis Inhibitor [EPC] 1
77 Sulfonamide Antimicrobial [EPC] 1
78 Sulfone [EPC] 1
79 Sympathomimetic-like Agent [EPC] 1
80 Thalidomide Analog [EPC] 1
81 Thiazide-like Diuretic [EPC] 1
82 Vitamin D Analog [EPC] 1
83 Vitamin D2 Analog [EPC] 1
84 Xanthine Oxidase Inhibitor [EPC] 1
85 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1